|
BALTIMORE, Md.—January 16, 2013—Parkinson disease (PD) is a complex, progressive, neurologic disorder, affecting approximately 1% of individuals older than 60 years. Med-IQ, an ACCME-accredited provider of continuing medical education (CME), developed a complimentary, certified CME series to help neurologists better manage patients with PD. “This complimentary CME series integrates current evidence with expert perspectives to equip neurologists with data-driven strategies and best practices for the management of their patients with PD,” said William A. Mencia, MD, CCMEP, Vice President of Education and Medical Affairs at Med-IQ. “Additionally; the series provides learning opportunities in multiple formats so neurologists can choose the medium that best suits their learning styles and preferences.”
The Optimal Management Strategies in PD: A Multi-Component Initiative Synthesizing Expert Perspectives and Clinical Data
| Faculty |
| |
Robert A. Hauser, MD, MBA
Professor of Neurology, Molecular Pharmacology, and Physiology
Director, USF Parkinson’s Disease and Movement Disorders Center
USF Health Byrd Institute
Tampa, FL
|
|
| |
Claire Henchcliffe, MD, DPhil
Associate Professor of Neurology and Neuroscience
Weill Cornell Medical College
Associate Attending Neurologist
New York-Presbyterian Hospital
Director of the Parkinson’s Institute at the New York-Presbyterian Hospital/Weill
Cornell Medical Center
New York, NY
|
|
This interactive, discussion-based CME Webcast integrates insights from leading experts in PD with contemporary clinical evidence regarding the treatment of patients with this condition. “Dr. Hauser and I will address the benefits and risks of available treatment options and optimal strategies for identifying and managing treatment-related and non-motor symptoms to improve quality of life for patients living with PD,” said Claire Henchcliffe, MD, DPhil. “We will also discuss current guideline recommendations, evidence-based treatment options, and recent clinical data on the management of PD.”
Four complimentary activities available:
- Contemporary Evidence, Changing Science, and Future Perspectives: A Clinician Exchange on the Management of Parkinson Disease (Webcast)
- What Is the Evidence? A Treatment Road Map for the Newly Diagnosed Patient With Mildly Symptomatic Parkinson Disease (Webcast)
- Addressing Treatment Complications for the Parkinson Patient on Chronic Levodopa Therapy (Webcast)
- Trials to Treatments: Evidence-Based Approaches to Maximizing Outcomes in Early and Advanced PD (Publication)
Interested clinicians are invited to learn more by visiting www.Med-IQ.com/s46
This activity has been approved for AMA PRA Category 1 Credit™
Sponsored by Med-IQ.
© 2013 Med-IQ. All rights reserved.
This activity is supported by an educational grant from Teva Pharmaceuticals.
For more information, call (toll-free) 866 858 7434, e-mail info@med-iq.com, or visit www.Med-IQ.com/a687.
|
About Med-IQ
Med-IQ, America's most respected provider of continuing medical education (CME), inspires healthcare professionals through award-winning activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively.
Med-IQ, a leader in the development of performance improvement (PI) and quality improvement (QI) CME initiatives, has been recognized by the Alliance for Continuing Education in the Health Professions for our excellence in CE research (William Campbell Felch Award 2013, 2011), educational collaborations (2013), outstanding CME outcomes assessment (2012), and exceptional leadership (Leadership Award 2013, President’s Award 2012). To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, connect with us on LinkedIn, and visit our YouTube channel.
For more information, contact: |
close
